Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
Status:
Unknown status
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Treatment of macular edema secondary to central retinal vein occlusion is more effective with
combined therapy of bevacizumab and triamcinolone than bevacizumab alone.